Recombinant Protein Industry To Grow at 8.6 % of CAGR By 2025 – Industry Size, Share, Top Leading Companies and Forecast Research

The Global Recombinant Protein Market was valued at USD 340.3 million in 2016, and is expected to grow at a CAGR of 8.6% by 2025. The prevalence of chronic diseases, such as cancer, diabetes, and arthritis, are on the rise, internationally, as well as the treatment of the aforementioned diseases. As per the statistics recorded by the World Health Organization, the number of people with diabetes increased to 422 million in 2014, and in 2015, approximately 1.6 million deaths were directly caused due to diabetes and its associated complications.

For Sample Copy of this Report @ https://www.orianresearch.com/request-sample/663072 .

Based on End user, Biopharmaceutical organizations are focusing on research and development of novel biosimilars for life threatening diseases such as cardiovascular diseases, cancer, metabolic disorders such as diabetes, and certain rare conditions such as hemophilia.

Although academic & research institutes are anticipated to remain the largest end-users of recombinant proteins in terms of revenues, sales in biopharmaceutical companies will register the highest CAGR compared to all the other end-user segments through 2022. Revenues from sales of recombinant proteins in academic & research institutes will account for over one-third market share during 2017 to 2022.

Advancement in technologies in various areas associated with or facilitating recombinant protein production have supported growth of recombinant protein market. For instance, development of alternative expression technologies such as mammalian cell expression, baculovirus expression, and E.coli expression, development of alternative cell lines, and enhanced cell culture systems have simplified and optimized recombinant protein processes.

Some of the key players operating in this market include Crown Bioscience, Inc., ProSpec Tany TechnoGene, Ltd., BPS Bioscience, Inc., Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech, Inc., Feldan Bio, Inc., BioVision, Inc., HumanZyme, Inc., and GenScript Biotech Corporation, and Others.

Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/663072 .

Key Benefits of the Report:

* Global, Regional, Country, End User, and Product Type Market Size and Forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, Product Type & End User, and competitive landscape with qualitative and quantitative information and facts

Target Audience:
* Vaccine adjuvants manufacturers and suppliers
* Academic research institutes
* Biopharmaceutical and biotechnology companies
* Research and development (R&D) companies
* Business research and consulting service providers
* Medical research laboratories
* Academic medical centers and universities

Get Direct Copy of this Report @ https://www.orianresearch.com/checkout/663072 .

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity production, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:

* Original Equipment Manufacturer,
* Component Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute

TABLE OF CONTENT
1 Executive Summary
2 Methodology And Market Scope
3 Recombinant Protein Market — Industry Outlook
4 Recombinant Protein Market Product Type Outlook
5 Recombinant Protein Market End User Outlook
6 Recombinant Protein Market Regional Outlook
7 Competitive Landscape
End of the report
Disclaimer

About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world’s most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.